Lung cancer patients can be screened for ALK-inhibitor suitability
Anaplastic lymphoma kinase gene status in patients with lung adenocarcinoma can be determined non-invasively using circulating tumor cells, research shows.
Original Article: Lung cancer patients can be screened for ALK-inhibitor suitability
NEXT ARTICLE